Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab

Nivolumab and ipilimumab (NIVO + IPI) is standard therapy for patients with advanced renal cell carcinoma (RCC). Absolute lymphocyte count (ALC) is a valuable prognostic factor in patients with various cancers treated with immune checkpoint inhibitors. Herein, we determined the prognostic value of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Kosuke, Ogasawara, Naoyuki, Ito, Naoki, Ohnishi, Satoshi, Suekane, Hiroki, Kurose, Hirofumi, Hiroshige, Tasuku, Chikui, Katsuaki, Uemura, Keiichiro, Nishihara, Kiyoaki, Nakiri, Makoto, Suekane, Shigetaka, Igawa, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053370/
https://www.ncbi.nlm.nih.gov/pubmed/36983417
http://dx.doi.org/10.3390/jcm12062417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053370/
https://www.ncbi.nlm.nih.gov/pubmed/36983417
http://dx.doi.org/10.3390/jcm12062417

Ejemplares similares